DESCRIPTION

Inhaled drug products are becoming increasingly popular for local or systemic therapies via the lungs or nasal mucosa. Consequently, the market for inhaled drugs is very important and the requirements from regulatory authorities are increasing. The New Cascade Impactor (NGI) has been designed specifically for testing pharmaceutical inhaled products.
This course introduces theoretical and practical concepts about key aspects of testing products for nasal and pulmonary drug delivery.

Contents:

• Current test requirements
• NGI operating principles
• Dose content uniformity test
• Aerodynamic diameter distribution
• Data analysis and plots.

TARGET AUDIENCE

Scientists, managers, technicians in the pharmaceutical industry or quality control labs, regulatory authorities and inspectors.

INSTRUCTORS

F. Cabrera, L. Gallo,V. Bucalá, V. Ramírez Rigo